Repolarizing the activated microglia into a homeostatic phenotype after CSF1R inhibition has also been observed in models of multiple sclerosis (Nissen et al., 2018) and Parkinson's disease (Neal et al., 2020). The gene discussed is CSF1R; the disease is Parkinson disease.